QCM
DXCM icon

Qsemble Capital Management’s DexCom DXCM Stock Holding History

Qsemble Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-69,122
Closed -$4.72M – 472
2025
Q1 		$4.72M Buy
+69,122
New +$5.64M 0.5% 64
2024
Q4 		– Sell
-41,449
Closed -$2.78M – 424
2024
Q3 		$2.78M Buy
41,449
+36,811
+794% +$3.02M 0.51% 63
2024
Q2 		$526K Buy
4,638
+121
+3% +$15.3K 0.1% 280
2024
Q1 		$627K Buy
+4,517
New +$568K 0.14% 242
2023
Q1 		– Sell
-1,800
Closed -$204K – 269
2022
Q4 		$204K Buy
+1,800
New +$198K 0.14% 209

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Qsemble Capital Management's DXCM Position: Q2 2025 in Review

Qsemble Capital Management sold out of DexCom (DXCM) in Q2 2025, closing a stake of 69,122 shares — an estimated $4.72M sold.

Qsemble Capital Management first reported a position in DXCM in Q4 2022 and held it in 5 quarters. The position peaked at $4.72M in Q1 2025. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • Qsemble Capital Management reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • Qsemble Capital Management sold 69,122 DexCom shares in Q2 2025, an estimated $4.72M.
  • Qsemble Capital Management first reported a position in DexCom in Q4 2022 and held it in 5 quarters.
  • Qsemble Capital Management's DexCom position peaked at $4.72M in Q1 2025.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Qsemble Capital Management's 13F filing for Q2 2025, filed 11 Aug 2025.